BERLIN, Nov 10 (Reuters) - German Health Minister Jens Spahn expects a final purchase agreement with BioNTech and its partner Pfizer to be signed “in the coming days” for its potential vaccine against COVID-19.
“We will now bring this to a speedy conclusion,” Spahn told a news conference in Berlin.
Spahn said he expects Germany will get up to 100 million doses of the BioNTech-Pfizer vaccine.
Reporting by Caroline Copley Editing by Michelle Adair
Our Standards: The Thomson Reuters Trust Principles.